Shanghai Junshi Biosciences Co., Ltd. Class H ( (HK:1877) ) just unveiled an update.

Shanghai Junshi Biosciences has called its first extraordinary general meeting of 2026 for July 27 in Shanghai, inviting holders of its H shares to vote on a special resolution granting the board a general mandate to repurchase the company’s H shares. The meeting will be conducted by poll under Hong Kong listing rules, with a defined share registration cutoff and proxy procedures, underscoring the company’s use of share buybacks as an active capital management tool for its Hong Kong-listed equity.

The register of H-share members will be closed from July 22 to July 27 to determine eligibility to attend and vote, requiring transfers to be lodged by July 21. The notice applies specifically to H-shareholders, with a separate notice issued to A-shareholders on the Shanghai Stock Exchange, highlighting coordinated governance across the firm’s dual-listing structure and giving stakeholders clarity on participation mechanics and rights.

The most recent analyst rating on (HK:1877) stock is a Hold
with a HK$34.70 price target.
To see the full list of analyst forecasts on Shanghai Junshi Biosciences Co., Ltd. Class H stock,
see the HK:1877 Stock Forecast page.